glp-1 news today october 2025 Regulating a "Miracle Drug": Costs, Access, & Safety Perspectives from employers on the
Description
The Unmet Challenge of Medication Nonadherence
The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.
Each month includes your customized microdose, injection supplies, free shipping, and ongoing provider support no insurance needed
What you need to know is covered in this article and infographic
A massive new study shows GLP-1 drugs like semaglutide don't just help with weight and blood sugar
